BioCentury
ARTICLE | Company News

Solvay, Petrovax flu vaccine deal

November 18, 2004 8:00 AM UTC

Petrovax (Moscow, Russia) and Solvay Pharmaceuticals, a unit of Solvay (Euronext:SOLB), will build a facility to produce a next-generation flu vaccine in Russia using antigens from Solvay's cell cultu...